Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 7, 2011, Pages 933-937

  Zachariah, R ^a   Bemelmans, M ^b   Akesson, A ^b   Gomani, P ^b   Phiri, K ^b   Isake, B ^c   Van Den Akker, T ^b   Philips, M ^d   Mwale, A ^e   Gausi, F ^e   Kwanjana, J ^c   Harries, A D ^f,g  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MSF ^*  (Malawi)

^c MINISTRY OF HEALTH   (Malawi)

^d MSF   (Belgium)

^e Regional TB Office   (France)

^f INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

ART; Case notification; Malawi; Scale up; TB

Indexed keywords

ANTIMICROBIAL THERAPY; ANTIRETROVIRAL TREATMENT; ARTICLE; HEALTH CARE ACCESS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALAWI; PRIORITY JOURNAL; RECURRENT DISEASE; RURAL AREA; SCALE UP; TREND STUDY; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; DISEASE NOTIFICATION; HIV INFECTIONS; HUMANS; MALAWI; RECURRENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 79958703449     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0666     Document Type: Article

References (31)

1. Raviglione M C, Harries A D, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa. AIDS 1997; 11 (Suppl B): S115-S123.
2. Di Perri G, Cruciani M, Danzi M C, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989; 2: 1502-1504. (Pubitemid 20018152)
3. Grant A D, Djomand G, De Cock K M. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997; 11 (Suppl B): S43-S54.
4. Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Trop Med Int Health 2005; 10: 734-742. (Pubitemid 41098140)
5. Korenromp E L, Scano F, Williams B G, Dye C, Nunn P. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis 2003; 37: 101-112. (Pubitemid 36836652)
6. Sonnenberg P, Murray J, Glynn J R, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse and re-infection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358: 1687-1693. (Pubitemid 33124328)
7. Lawn S D, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med 2009; 30: 685-699, viii.
8. Harries A D, Hargreaves N J, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357: 1519-1523. (Pubitemid 32488877)
9. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064. (Pubitemid 34680968)
10. Girardi E, Antonucci G, Vanacore P, et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 2000; 14: 1985-1991.
11. Jones J L, Hanson D L, Dworkin M S, De Cock K M. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis 2000; 4: 1026-1031.
12. Tabarsi P, Saber-Tehrani A S, Baghaei P, et al. Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV. J Int AIDS Soc 2009; 12: 14.
13. Nahid P, Gonzalez L C, Rudoy I, et al. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 2007; 175: 1199-1206. (Pubitemid 46855463)
14. Ministry of Health and Population. HIV and syphilis sero-survey and national HIV prevalence and AIDS estimates report (surveillance survey report). Lilongwe, Malawi: MOHP, 2007.
15. Mwamgomba B Z R, Massaquoi M, Misindi D, et al. Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PloS One 2010; 5: e10452.
16. Bemelmans M, Van den Akker T, Ford N, et al. Providing universal access to antiretroviral therapy in Thyolo, Malawi, through task-shifting and decentralization of HIV/AIDS care. Trop Med Int Health 2010; 15: 1413-1420.
17. Zachariah R, Spielmann M P, Chinji C, et al. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 2003; 17: 1053-1061. (Pubitemid 36549718)
18. Manzi M, Zachariah R, Teck R, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health 2005; 10: 1242-1250. (Pubitemid 41789677)
19. Malawi National TB Control Programme. Manual of the National Tuberculosis Control Programme in Malawi. Lilongwe, Malawi: Ministry of Health and Population, 1987.
20. Ministry of Health and Population and National AIDS Commission. Guidelines for the use of anti-retroviral therapy in Malawi. Lilongwe, Malawi: MOHP, 2006.
21. National Statistics Office. Population figures by year for Thyolo District. Zomba, Malawi: National Population Statistics Office, 2007.
22. Lawn S D, Kranzer K, Edwards D J, Wood R. Screening for active tuberculosis among patients accessing antiretroviral therapy in sub-Saharan Africa. Int J Tuberc Lung Dis 2009; 13: 1186-1187; author reply 7-8.
23. Lawn S D, Wilkinson R J, Lipman M C, Wood R. Immune reconstitution and 'unmasking' of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 2008; 177: 680-685. (Pubitemid 351490554)
24. Zachariah R, Teck R, Buhendwa L, et al. How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in Malawi. Trans R Soc Trop Med Hyg 2006; 100: 167-175. (Pubitemid 43024773)
25. Aït-Khaled N, Alarcon E, Bissell K, et al. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis 2009; 13: 927-935.
26. Médecin sans Frontière. Increasing access to antiretroviral care in rural Malawi. 2003-2009 Programme report. Paris, France: MSF, 2009. http://aids2010.msf.org/up-content/uploads/Increasing-access-to-ARV-Care-Malawi- 2009.pdf Accessed September 2010.
27. Musili J W. An econometric model of the Malawian economy. Economic Modelling 2002; 19: 295-230.
28. United Nations. United Nations Millennium Development Goals. New York, NY, USA: UN, 2010. http://www.un.org/millenniumgoals/ Accessed April 2011.
29. Atun R, Raviglione M, Marais B, Zumla A. Tuberculosis control is crucial to achieve the MDGs. Lancet 2010; 376: 940-941.
30. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2010 revision. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/publications/ 2010/9789241599764-eng.pdf Accessed April 2011.
31. Harries A D, Zachariah R, Corbett E L, et al. The HIV-associated tuberculosis epidemic - when will we act? Lancet 2010; 375: 1906-1919.